Team:UGent/Ethics
From 2013.igem.org
(21 intermediate revisions not shown) | |||
Line 25: | Line 25: | ||
</p> | </p> | ||
+ | <br> | ||
<div> | <div> | ||
<a href="https://2013.igem.org/Team:UGent/Ethics/Prof_dr_ir_Wim_Soetaert" target="_blank"> | <a href="https://2013.igem.org/Team:UGent/Ethics/Prof_dr_ir_Wim_Soetaert" target="_blank"> | ||
- | <img src="https://static.igem.org/mediawiki/2013/9/9f/UGent_2013_Prof_dr_ir_Wim_Soetaert_SQ.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2013/9/9f/UGent_2013_Prof_dr_ir_Wim_Soetaert_SQ.jpg" width="190px" |
- | onmouseover="this.src='https://static.igem.org/mediawiki/2013/ | + | onmouseover="this.src='https://static.igem.org/mediawiki/2013/5/53/UGent_2013_Citaat_foto_WS_bijgesneden.jpg';"" |
onmouseout="this.src='https://static.igem.org/mediawiki/2013/9/9f/UGent_2013_Prof_dr_ir_Wim_Soetaert_SQ.jpg';"/> | onmouseout="this.src='https://static.igem.org/mediawiki/2013/9/9f/UGent_2013_Prof_dr_ir_Wim_Soetaert_SQ.jpg';"/> | ||
- | </ | + | </a> |
- | + | ||
<a href="https://2013.igem.org/Team:UGent/Ethics/Prof_dr_Tom_Desmet" target="_blank"> | <a href="https://2013.igem.org/Team:UGent/Ethics/Prof_dr_Tom_Desmet" target="_blank"> | ||
- | <img src="https://static.igem.org/mediawiki/2013/d/dc/UGent_2013_Prof_dr_Tom_Desmet_SQ.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2013/d/dc/UGent_2013_Prof_dr_Tom_Desmet_SQ.jpg" width="190px" |
- | onmouseover="this.src='https://static.igem.org/mediawiki/2013/ | + | onmouseover="this.src='https://static.igem.org/mediawiki/2013/e/ee/UGent_2013_Citaat_foto_TD_bijgesneden.jpg';"" |
- | onmouseout="this.src='https://static.igem.org/mediawiki/2013/d/dc/UGent_2013_Prof_dr_Tom_Desmet_SQ.jpg'';"/> | + | onmouseout="this.src='https://static.igem.org/mediawiki/2013/d/dc/UGent_2013_Prof_dr_Tom_Desmet_SQ.jpg';"/> |
+ | </a> | ||
+ | |||
+ | <a href="https://2013.igem.org/Team:UGent/Ethics/Prof_dr_Geert_De_Jaeger" target="_blank"> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/d/d6/UGent_2103_IMG2_4124vibhildeendejager_SQ.jpg" width="190px" | ||
+ | onmouseover="this.src='https://static.igem.org/mediawiki/2013/c/cc/UGent_2013_Citaat_foto_GDJ_bijgesneden.jpg';"" | ||
+ | onmouseout="this.src='https://static.igem.org/mediawiki/2013/d/d6/UGent_2103_IMG2_4124vibhildeendejager_SQ.jpg';"/> | ||
+ | </a> | ||
+ | |||
+ | <a href="https://2013.igem.org/Team:UGent/Ethics/Prof_dr_Els_Van_Damme" target="_blank"> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/c/c7/UGent_2013_Prof_dr_Els_Van_Damme_SQ.jpg" width="190px" | ||
+ | onmouseover="this.src='https://static.igem.org/mediawiki/2013/1/10/UGent_2013_Citaat_foto_EVD_bijgesneden.jpg';"" | ||
+ | onmouseout="this.src='https://static.igem.org/mediawiki/2013/c/c7/UGent_2013_Prof_dr_Els_Van_Damme_SQ.jpg';"/> | ||
+ | </a> | ||
+ | |||
+ | <a href="https://2013.igem.org/Team:UGent/Ethics/Prof_dr_Filip_Buekens" target="_blank"> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/b/bd/UGent_2013_Prof_dr_Buekens_SQ.jpg" width="190px" | ||
+ | onmouseover="this.src='https://static.igem.org/mediawiki/2013/6/6c/UGent_2013_Citaat_foto_FB_bijgesneden.jpg';"" | ||
+ | onmouseout="this.src='https://static.igem.org/mediawiki/2013/b/bd/UGent_2013_Prof_dr_Buekens_SQ.jpg';"/> | ||
+ | </a> | ||
</div> | </div> | ||
+ | <br> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<h1>What we take home</h1> | <h1>What we take home</h1> | ||
<p>It is clear that synthetic biology will lead to tons of new applications in the near future and that it is impossible to foresee all the long-term consequences. Does this mean we should act out of a precautionary principle and not proceed at all? No! We opt, just like the professionals we interviewed, for a more <b>proactionary approach</b> and hope Europe will soon follow this philosophy. We do not think progress should be halted by worrying about unforeseeable consequences. The focus should not be on eliminating all risks, as zero-risk is utopian (cfr. Prof. Wim Soetaert). Note that we absolutely agree that foreseeable consequences should be thoroughly evaluated and that a <b>cost-benefit analysis</b> should be made (cfr. Prof. Filip Buekens). | <p>It is clear that synthetic biology will lead to tons of new applications in the near future and that it is impossible to foresee all the long-term consequences. Does this mean we should act out of a precautionary principle and not proceed at all? No! We opt, just like the professionals we interviewed, for a more <b>proactionary approach</b> and hope Europe will soon follow this philosophy. We do not think progress should be halted by worrying about unforeseeable consequences. The focus should not be on eliminating all risks, as zero-risk is utopian (cfr. Prof. Wim Soetaert). Note that we absolutely agree that foreseeable consequences should be thoroughly evaluated and that a <b>cost-benefit analysis</b> should be made (cfr. Prof. Filip Buekens). | ||
Line 55: | Line 69: | ||
<br><br> | <br><br> | ||
Starting now, we should <b>inform and educate</b> the general public about synthetic biology and the advantages that come with it, in order to prevent an irrational, sentimental aversion (cfr. GMOs). What stood out to us when discussing this topic with Prof. Buekens was the importance of <b>semantics</b>. Today many words associated with genetic engineering evoke rather negative emotions as a result of the anti-campaign against GMOs. This is why we created <b>a lexicon for communicating synthetic biology to the broad public</b>. | Starting now, we should <b>inform and educate</b> the general public about synthetic biology and the advantages that come with it, in order to prevent an irrational, sentimental aversion (cfr. GMOs). What stood out to us when discussing this topic with Prof. Buekens was the importance of <b>semantics</b>. Today many words associated with genetic engineering evoke rather negative emotions as a result of the anti-campaign against GMOs. This is why we created <b>a lexicon for communicating synthetic biology to the broad public</b>. | ||
+ | <br><br> | ||
</p> | </p> | ||
<h1>The Synbio Lexicon - a new tool for communicating synthetic biology</h1> | <h1>The Synbio Lexicon - a new tool for communicating synthetic biology</h1> | ||
Line 62: | Line 77: | ||
<br><br> | <br><br> | ||
We established a lexicon that contains a collection of terms, words, sentences, that may evoke negative sentiments or make people yawn and proposed a more neutral, accessible alternative. | We established a lexicon that contains a collection of terms, words, sentences, that may evoke negative sentiments or make people yawn and proposed a more neutral, accessible alternative. | ||
+ | <center> <img src="https://static.igem.org/mediawiki/2013/d/d9/UGent_2013_The_Synbio_Lexicon.jpg" width="700" hspace="20"> </center> | ||
</p> | </p> | ||
- | <br><br> | + | |
+ | <h1>Sources</h1> | ||
+ | Newson, A.J. Current Ethical Issues in Synthetic Biology: Where Should We Go from Here? <i>Accountability in Research-Policies and Quality Assurance</i> <b>18</b>, 181-193 (2011).<br> | ||
+ | Parens, E. <i>et al.</i> (2009) Ethical issues in synthetic biology. http://www.synbioproject.org/library/publications/archive/synbio3/ (read 23/08/13)<br> | ||
+ | Schmidt, M. A priority paper for the societal and ethical aspects of synthetic biology. <i>Systems and Synthetic Biology</i> <b>3</b>, 3-7 (2009)<br> | ||
+ | Sommerville, M. (2007) Patenting life. http://www.mercatornet.com/articles/view/patenting_life (read 23/08/13)<br> | ||
+ | Velasquez, M. <i>et al.</i> (2010) What is Ethics? http://www.scu.edu/ethics/practicing/decision/whatisethics.html (read 23/08/13) <br><br> | ||
+ | |||
+ | |||
+ | |||
</html> | </html> | ||
{{:Team:UGent/Templates/Footer}} | {{:Team:UGent/Templates/Footer}} | ||
{{:Team:UGent/Templates/BaseSponsor}} | {{:Team:UGent/Templates/BaseSponsor}} |
Latest revision as of 16:25, 4 October 2013
Ethics in synthetic biology
It is not surprising that synthetic biology, the science which adapts and designs living organisms with myriad and undefined applications, has a broad ethical dimension. An ethical dimension … ethical questions … ethics … what on earth? Weren’t we talking exact science here?
The first question that springs to mind when considering new technologies is about the still unknown, potentially harmful consequences. A synthetic organism may have negative effects on the environment or human beings. Such concerns fall under biosafety. Is it acceptable to create something which we do not know the long-term consequences of? Apart from biosafety, synthetic biology raises also biosecurity concerns, as products of synthetic biology could potentially be used for acts of bioterrorism.
One of the goals of synthetic biology is the creation of new organisms with functions that are not found in nature. Also the creation of minimal organisms from the ground up is an application of synthetic biology. Is the creation of novel entities like microorganisms creating life or merely building a biological machine? Is creating life acceptable? Could this change our view on the concept of life or alter our relationship with other living creatures?
What we take homeIt is clear that synthetic biology will lead to tons of new applications in the near future and that it is impossible to foresee all the long-term consequences. Does this mean we should act out of a precautionary principle and not proceed at all? No! We opt, just like the professionals we interviewed, for a more proactionary approach and hope Europe will soon follow this philosophy. We do not think progress should be halted by worrying about unforeseeable consequences. The focus should not be on eliminating all risks, as zero-risk is utopian (cfr. Prof. Wim Soetaert). Note that we absolutely agree that foreseeable consequences should be thoroughly evaluated and that a cost-benefit analysis should be made (cfr. Prof. Filip Buekens).
The Synbio Lexicon - a new tool for communicating synthetic biologyWe found that there is a deep rooted, irrational disgust among a large part of the general public for things associated with genetic engineering. Several campaigns against the use of GMOs have severely damaged the image of scientific disciplines that make use of the adaptation of genes of living organisms. That’s why it’s very important to use a (new) vocabulary that does not evoke these negative feelings when communicating with the public. After all, humans are sentimental beings and education alone will not bring us a step closer to general acceptance if negative emotions keep having the upper hand.
SourcesNewson, A.J. Current Ethical Issues in Synthetic Biology: Where Should We Go from Here? Accountability in Research-Policies and Quality Assurance 18, 181-193 (2011).Parens, E. et al. (2009) Ethical issues in synthetic biology. http://www.synbioproject.org/library/publications/archive/synbio3/ (read 23/08/13) Schmidt, M. A priority paper for the societal and ethical aspects of synthetic biology. Systems and Synthetic Biology 3, 3-7 (2009) Sommerville, M. (2007) Patenting life. http://www.mercatornet.com/articles/view/patenting_life (read 23/08/13) Velasquez, M. et al. (2010) What is Ethics? http://www.scu.edu/ethics/practicing/decision/whatisethics.html (read 23/08/13)
|
Tweets van @iGEM_UGent |
|